Drug profile · INN
ertapenem
INVANZ
ertapenem (INVANZ) is a bacterial penicillin-binding protein inhibitor.
EMA: approved Antiinfectives for systemic use (J01) J01DH03
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — ertapenem
- Class
- Antiinfectives for systemic use (J01)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
ertapenem (INVANZ) is a bacterial penicillin-binding protein inhibitor.
Key facts
INN ertapenem
Brand INVANZ
Mechanism Bacterial penicillin-binding protein inhibitor
Target Bacterial penicillin-binding protein
Therapeutic class Antiinfectives for systemic use (J01)
ATC code J01DH03
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is ertapenem?
ertapenem (INVANZ) is a bacterial penicillin-binding protein inhibitor.
What is the brand name for ertapenem?
INVANZ is a marketed brand name for ertapenem. Check FDA Drugs@FDA for the current US label holder and prescribing information.